Response to ropinirole in restless legs syndrome is independent of baseline serum ferritin.
Morgan
John C
JC
Ames
Michael
M
Sethi
Kapil D
KD
D018491:Dopamine Agonists / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005293:Ferritins / Q000097:blood*; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012148:Restless Legs Syndrome / Q000097:blood / Q000188:drug therapy*; D016896:Treatment Outcome
D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole; D005293:Ferritins